NTRK fusion-positive solid tumors | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

51,580 results for “NTRK fusion-positive solid tumors”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors

29 participants · First posted May 26, 2021

A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors

215 participants · First posted Oct 15, 2015

Repotrectinib Post-Marketing Surveillance in Pediatric Patients With NTRK Fusion-Positive Tumors in Japan

20 participants · First posted Aug 10, 2026

Study of ONO-7579 in Patients With Advanced Solid Tumors/ NTRK Gene Fusion Positive Advanced Solid Tumors

1 participants · First posted Jun 9, 2017

NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes

100 participants · First posted Jun 30, 2021

An Observational Study to Learn More About NTRK Gene Fusion Positive in Solid Tumor in Japan

46,621 participants · First posted Mar 31, 2023

A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors

360 participants · First posted Aug 9, 2021

Active, not recruiting

NTRK 1,2,3 Rearrangements in Patients With Solid Tumors

5,000 participants · First posted Jan 17, 2025

Phase II Study of AB-106 to Treat Patients With Solid Tumors With NTRK Gene Fusion

14 participants · First posted Nov 5, 2020

Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors

13 participants · First posted May 10, 2021

Page 1 of 3590